Freedman S B, Patel S, Harley E A, Iversen L L, Baker R, Showell G A, Saunders J, McKnight A, Newberry N, Scholey K
Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex, UK.
Eur J Pharmacol. 1992 Apr 29;215(1):135-6. doi: 10.1016/0014-2999(92)90618-e.
The oxadiazole L-687,306 is a high affinity muscarinic agonist with a N-methylscopolamine/oxotremorine-M binding profile predictive of a partial agonist. L-687,306 showed marked selectivity in functional pharmacological assays. L-687,306 was a partial agonist at muscarinic M1 receptors in the rat ganglion but a high affinity competitive antagonist at guinea-pig cardiac M2 and ileal M3 muscarinic receptors. This compound gives an opportunity to study receptor reserve involved in muscarinic receptors in vitro and in vivo.
恶二唑L-687,306是一种高亲和力的毒蕈碱激动剂,其N-甲基东莨菪碱/氧化震颤素-M结合特征表明它是一种部分激动剂。L-687,306在功能药理学试验中表现出显著的选择性。L-687,306在大鼠神经节的毒蕈碱M1受体上是一种部分激动剂,但在豚鼠心脏M2和回肠M3毒蕈碱受体上是一种高亲和力竞争性拮抗剂。该化合物为在体外和体内研究毒蕈碱受体中的受体储备提供了机会。